台灣臨床試驗主持人資料庫|TPIDB

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberI3O-MC-JSBF

Completed

2016-05-01 - 2020-12-31

Phase II

Terminated5

ICD-10D01.5

Carcinoma in situ of liver, gallbladder and bile ducts

ICD-10C22.0

Liver cell carcinoma

ICD-10C22.1

Intrahepatic bile duct carcinoma

ICD-10C24

Malignant neoplasm of other and unspecified parts of biliary tract

ICD-10C24.9

Malignant neoplasm of biliary tract, unspecified

ICD-9230.8

Carcinoma in situ of liver and biliary system

Trial Applicant

ELI LILLY AND COMPANY(TAIWAN), INC.
Sponsor
Trial scale

Multi-Regional Multi-Center
Update

2026/04/01

Investigators and Locations

Principal Investigator Li-Tzong Chen Division of Hematology & Oncology

National Taiwan University Hospital

Co-Principal Investigator

Nai-Jung Chiang Division of Hematology & Oncology
Shang-Hung Chen Division of Hematology & Oncology
Yan-Shen Shan Division of General Surgery
Kwang-Yu Chang Division of Hematology & Oncology
姜乃榕 Division of Hematology & Oncology
Hui-Jen Tsai Division of Hematology & Oncology
Chia-Jui Yen Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Terminated

Audit

None

Principal Investigator Yee Chao Division of Hematology & Oncology

Taipei Veterans General Hospital

Co-Principal Investigator

Rheun-Chuan Lee Division of Radiology
Yi-Hsiang Huang Digestive System Department
Chung-Pin Li Digestive System Department
Yi-Ping Hung Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

3 Terminated

Audit

None

Principal Investigator Li-Yuan Bai Division of Hematology & Oncology

China Medical University Hospital

Co-Principal Investigator

Chang-Fang Chiu Division of Hematology & Oncology
Che-Hung Lin Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Tai-Jan Chiu Division of Hematology & Oncology

Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.

Co-Principal Investigator

陳彥仰 Division of Hematology & Oncology
陳彥豪 Division of Hematology & Oncology
饒坤銘 Division of Hematology & Oncology
廖浚凱 Division of Hematology & Oncology
Yu-Li Su Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Li-Yuan Bai 未分科

China Medical University Hospital-Taipei

Co-Principal Investigator

Audit

CRO

Principal Investigator Jen-Shi Chen Division of Hematology & Oncology

Linkou Chang Gung Medical Foundation

Taiwan National PI

陳仁熙

Co-Principal Investigator

Tsai-Sheng Yang Division of Hematology & Oncology
Yung-Chia Kao Division of Hematology & Oncology
Wen-Chi Chou Division of Hematology & Oncology
Chia-Hsun Hsieh Division of Hematology & Oncology
Chan-Keng Yang Division of Hematology & Oncology
Ming-Mo Hou Division of Hematology & Oncology
Po-Jung Su Division of Hematology & Oncology
Hung-Chih Hsu Division of Hematology & Oncology
Mengting Peng Division of Hematology & Oncology

Clinical Trials List

Investigators and Locations

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants